Trials / Unknown
UnknownNCT04144270
The Importance of Muscle Function in Patients With Disseminated Bladder Cancer
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 30 (estimated)
- Sponsor
- Rigshospitalet, Denmark · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study investigates if reduced muscle mass and muscle function predispose to poor completion of oncological treatment in patients with bladder cancer (including cancer of the renal pelvis, ureter and urethra) and if muscle mass and muscle function change during oncological treatment in these patients. It also evaluates biomarkers for sarcopenia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Evaluation of muscle mass and muscle function | Included patients have their muscle mass and muscle function evaluated before start on and after completion of oncological treatment. |
Timeline
- Start date
- 2019-11-18
- Primary completion
- 2021-04-01
- Completion
- 2021-04-01
- First posted
- 2019-10-30
- Last updated
- 2019-11-20
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT04144270. Inclusion in this directory is not an endorsement.